Keen to stay out front in cell therapy, Gilead's Kite builds its own viral vector manufacturing operations
Days after wooing Christi Shaw to the helm at Kite, Gilead is once again touting just how serious it is about growing its pioneering CAR …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
